Description
Eurofins Scientific: Initiation of Coverage- Is the Market Missing a Hidden Growth Revival Story?
Eurofins Scientific S.E. presented its fiscal year 2024 performance, outlining both achievements and areas of focus for future development. The results reveal a nuanced performance with some segments outperforming, while others faced challenges. On a positive note, Eurofins reported robust financial growth, with revenues increasing by 6.7% and an adjusted EBITDA margin of 22.3%, representing a 180 basis point improvement year-on-year.
Our Report Structure:
⦁ Company Overview
⦁ Investment Thesis
⦁ Key Drivers
⦁ Historical Quarterly Statement Analysis – Income Statement & Cash Flows
⦁ Historical Quarterly Balance Sheet Analysis
⦁ Historical Annual Financial Statement Analysis
⦁ Analysis Of Key Financial Ratios
⦁ Financial Forecasts For 3 Years
⦁ Forecasting The Capital Structure & Net Debt
⦁ Discounted Cash Flow Valuation
⦁ Trading Multiples
⦁ Key Risks
⦁ Disclosures
Want unlimited access to our reports? Purchase our $99 annual subscription!
